Market Closed

XRTX
XORTX Therapeutics
$ 1.10
19.57%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

XORTX Therapeutics News

Latest XORTX Therapeutics Stock News & XRTX Headlines

XORTX Patent Allowed for XRx-101 Program by Japan Patent Office
2 days ago | globenewswire.com
XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
2 months ago | globenewswire.com
XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
2 months ago | globenewswire.com
XORTX Re-Engages Investor Relations Program
2 months ago | globenewswire.com
XORTX Announces Termination and Postponement of Investor Relations Program
3 months ago | globenewswire.com
XORTX Announces Director Resignation
4 months ago | globenewswire.com
XORTX Appoints New Director
4 months ago | globenewswire.com
XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
5 months ago | globenewswire.com
XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange
5 months ago | globenewswire.com
XORTX Announces Closing of US$5 Million Public Offering
6 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

XRTX
XORTX Therapeutics
$ 1.10
19.57%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago